A systematic review explores how AI-based clinical decision support systems can enhance cardiovascular disease management while facing adoption and equity challenges.
Key Details
- 1Research from Flinders University reviews AI's role in cardiovascular care through CDSS.
- 2Study identifies workflow integration, usability, and workforce readiness as key barriers to adoption.
- 3Out of 700+ studies, 12 large, global studies were deeply assessed.
- 4Strong governance, organisational support, and regulatory alignment are crucial for sustainable AI implementation.
- 5AI systems could reduce diagnosis delays and improve care in underserved, rural settings.
- 6Equity issues persist due to potential dataset bias and lack of AI-integrated prevention protocols.
Why It Matters
There is significant promise for AI-driven CDSS to improve cardiovascular care management, which can inform implementation in radiology and related imaging fields. Understanding barriers to adoption, governance needs, and equity issues can help the radiology-AI community advance safe, effective, and equitable integration of AI tools.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
AI Deep Learning Model Enhances Echocardiogram RV Assessment and Prognosis
Researchers developed DROID-RV, a deep learning tool that automates right ventricular assessment from echocardiograms, showing strong prognostic links with cardiovascular outcomes.